Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • houkto
    Junior Member
    • Sep 2011
    • 5

    #1

    NGS whole genome sequence versus sequence capture for quality control

    Hi there,

    I am trying to compare NGS whole genome sequence data (two strains, one with x26 coverage and the other with x21 coverage) and custom agilent sequence capture of selected regions from the the above mentioned strains but with very high coverage (x10,000). Both data were analysed using the same pipeline.

    Aim:
    To get a percentage of how reliable my NGS data is compared to sequence capture.
    and the way I am thinking of doing it is by either extract the SNPs from NGS data SNPs/indel using the targeted regions that were used in the custom sequence capture and then compared how many snps were missed by the NGS analysis. or I can pull the snps at earlier point of the analysis.

    What I need to know is:
    (a)What i wanted to know is what do you think of this approach, specially i have not seen it yet done by other group yet ? (if it did could you please let me know about this article).

    (b) is there another way of comparing both dataset for quality control

    (c) Also I wanted to know what are other possible benefits from doing such comparison ? if you think it is a good idea?

    Cheers

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
17 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
22 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-13-2026, 09:56 AM
0 responses
22 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-09-2026, 11:14 AM
0 responses
27 views
0 reactions
Last Post SEQadmin2  
Working...